RA CAPITAL MANAGEMENT, L.P. Q1 2016 Filing
Filed May 16, 2016
Portfolio Value
$782.3B
Holdings
42
Report Date
Q1 2016
Filing Type
13F-HR
All Holdings (42 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | WVEWAVE LIFE SCIENCES LTD | 7,088,651 | $98.4B | 12.58% | |
| 2 | —ACHILLION PHARMACEUTICALS INC | 12,033,220 | $92.9B | 11.87% | |
| 3 | —AXOVANT SCIENCES LTD | 5,000,000 | $57.4B | 7.34% | |
| 4 | ACRSACLARIS THERAPEUTICS INC | 2,627,719 | $49.8B | 6.36% | |
| 5 | NKTREURNEKTAR THERAPEUTICS | 3,178,854 | $43.7B | 5.59% | |
| 6 | ASNDASCENDIS PHARMA A S | 2,161,366 | $40.1B | 5.12% | |
| 7 | TGTXTG THERAPEUTICS INC | 4,531,714 | $38.6B | 4.94% | |
| 8 | —AVEXIS INC | 1,361,582 | $37.1B | 4.74% | |
| 9 | CHRSCOHERUS BIOSCIENCES INC | 1,272,048 | $27.0B | 3.45% | |
| 10 | —ZOGENIX INC | 2,451,237 | $22.6B | 2.90% | |
| 11 | —ARENA PHARMACEUTICAL S INC | 9,364,105 | $18.4B | 2.36% | |
| 12 | ARDXARDELYX INC | 2,300,481 | $17.9B | 2.28% | |
| 13 | —AIMMUNE THERAPEUTICS INC | 1,292,940 | $17.5B | 2.24% | |
| 14 | —CELATOR PHARMACEUTICALS INC | 1,414,114 | $15.6B | 1.99% | |
| 15 | —AQUINOX PHARMACEUTICALS INC | 1,691,977 | $14.9B | 1.91% | |
| 16 | —CIDARA THERAPEUTICS INC | 1,174,219 | $14.9B | 1.91% | |
| 17 | GBYSANGAMO BIOSCIENCES INC | 2,212,036 | $13.4B | 1.71% | |
| 18 | —ACORDA THERAPEUTICS INC | 498,159 | $13.2B | 1.68% | |
| 19 | —DICERNA PHARMACEUTICALS INC | 2,428,571 | $13.0B | 1.66% | |
| 20 | —PROTEON THERAPEUTICS INC | 1,626,931 | $12.6B | 1.61% | |
| 21 | —STRONGBRIDGE BIOPHARMA PLC | 2,690,702 | $12.3B | 1.57% | |
| 22 | —DIMENSION THERAPEUTICS INC | 1,548,033 | $12.1B | 1.55% | |
| 23 | —ALCOBRA LTD | 3,032,911 | $11.5B | 1.47% | |
| 24 | —VITAE PHARMACEUTICALS INC | 1,575,000 | $10.4B | 1.33% | |
| 25 | COLLCOLLEGIUM PHARMACEUTICAL INC | 486,557 | $8.8B | 1.13% | |
| 26 | BCRXBIOCRYST PHARMACEUTICALS | 2,989,795 | $8.5B | 1.08% | |
| 27 | NTRANATERA INC | 783,520 | $7.5B | 0.95% | |
| 28 | —REGULUS THERAPEUTICS INC | 1,045,119 | $7.2B | 0.93% | |
| 29 | —AGILE THERAPEUTICS INC | 1,064,217 | $6.6B | 0.84% | |
| 30 | ONCBEIGENE LTD | 170,000 | $5.0B | 0.64% | |
| 31 | —TENAX THERAPEUTICS INC | 2,389,700 | $4.9B | 0.63% | |
| 32 | CLDNEUREIGER BIOPHARMACEUTICALS INC | 291,700 | $4.9B | 0.63% | |
| 33 | —ZYNERBA PHARMACEUTICALS INC | 507,191 | $4.8B | 0.61% | |
| 34 | —PRONAI THERAPEUTICS INC | 604,982 | $4.1B | 0.52% | |
| 35 | —APPLIED GENETIC TECHNOL CORP | 236,059 | $3.3B | 0.42% | |
| 36 | —ARCA BIOPHARMA INC | 778,211 | $2.7B | 0.35% | |
| 37 | —AKARI THERAPEUTICS PLC | 257,721 | $2.6B | 0.33% | |
| 38 | —NIVALIS THERAPEUTICS INC | 612,863 | $2.6B | 0.33% | |
| 39 | —NEURODERM LTD | 144,671 | $2.0B | 0.26% | |
| 40 | 2L9BLUEPRINT MEDICINES CORP | 56,442 | $1.0B | 0.13% | |
| 41 | —DERMA SCIENCES INC | 81,239 | $252.0M | 0.03% | |
| 42 | —AMPLIPHI BIOSCIENCES CORP | 53,600 | $211.0M | 0.03% |